Does benign multiple sclerosis today imply benign multiple sclerosis tomorrow?
Implications for treatment
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Whether there is a benign form of multiple sclerosis (MS) continues to be a controversial issue. Varying definitions, inadequacies in measurement tools of MS-related impairment, and differences in the interpretation of the same or similar data by different investigators make this a confusing but important topic for discussion.1–6 In this issue of Neurology, Sayao et al. report that MS patients with an Expanded Disability Status Scale (EDSS) score of ≤2 or ≤1 or no disability for ≥10 years' duration have a 70%, 90%, and 94% chance, respectively, of remaining benign (EDSS score ≤ 3) 10 years later in a large population-based study in British Columbia. The only factor associated with 20-year EDSS score was the 10-year EDSS score.7,8 The authors note that although the natural history is favorable for this cohort of patients, not all will remain “well” for the duration of their lives. Indeed, the authors emphasize that even patients with these mildest cases of MS may ultimately do poorly.
As Sayao et al. point out, their results differ somewhat from other studies.1,2,4,5 A recent population-based Olmsted County MS study reported that 93% (vs 70% in Sayao's study) of patients with EDSS score ≤ 2 for >10 years remained benign (EDSS score ≤ 3) a further 10 years later. The Olmsted County report, though a much smaller study, …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Disputes & Debates: Rapid online correspondence
NOTE: All authors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.
- Stay timely. Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- 200 words maximum.
- 5 references maximum. Reference 1 must be the article on which you are commenting.
- 5 authors maximum. Exception: replies can include all original authors of the article.
- Submitted comments are subject to editing and editor review prior to posting.